scholarly journals Prevalence of Staphylococcus aureus in wild hedgehogs (Erinaceus europaeus) and first report of mecC-MRSA in Hungary

2022 ◽  
pp. 152858
Author(s):  
Judit Sahin-Tóth ◽  
Ervin Albert ◽  
Alexandra Juhász ◽  
Ágoston Ghidán ◽  
János Juhász ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Erinaceus Europaeus ◽  
First Report

scholarly journals Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection etest and population analysis profiling

2012 ◽  
Vol 4 (1) ◽  
pp. 20 ◽  
Author(s):  
Siti Roszilawati Ramli ◽  
Hui-min Neoh ◽  
Muhammad Nazri Aziz ◽  
Salasawati Hussin
Keyword(s):  
Staphylococcus Aureus ◽  
Prevalence Rate ◽  
Population Analysis ◽  
Kuala Lumpur ◽  
Glycopeptide Resistance ◽  
Methicillin Resistant ◽  
First Report ◽  
Resistance Detection

In a 3-month study done in Hospital Kuala Lumpur (HKL), 7 out of 320 methicillin resistant <em>Staphylococcus aureus </em>isolates were confirmed as heterogeneous vancomycin intermediate S. aureus (hVISA) using the glycopeptide resistance detection e-test and population analysis, giving a prevalence rate of 2.19%. This is the first report of hVISA in Malaysia.

scholarly journals Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant Staphylococcus aureus

2020 ◽  
Vol 34 ◽  
pp. 205873842092571
Author(s):  
Chanmei Lv ◽  
Jiantao Lv ◽  
Yue Liu ◽  
Qifeng Liu ◽  
Dongna Zou
Keyword(s):  
Staphylococcus Aureus ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
First Line ◽  
Methicillin Resistant ◽  
First Report ◽  
First Line Therapy ◽  
Acute Hematogenous Osteomyelitis ◽  
Serious Infections ◽  
Daily Dose ◽  
Red Man Syndrome

The infection of the bone marrow system caused by methicillin-resistant Staphylococcus aureus (MRSA) leads to a variety of common diseases which usually occur in children under the age of 12. Vancomycin (VCM) is the first-line therapy for MRSA-caused serious infections such as bacteremia, infective endocarditis, osteomyelitis, meningitis, pneumonia, and severe skin and soft-tissue infection (e.g. necrotizing fasciitis) with a recommended dosage of 15–20 μg/mL. In this study, we first report a case of a child with MRSA-caused osteomyelitis who was successfully cured by VCM at a concentration of 4.86 μg/mL. VCM’s clinical daily dose of more than 4 g was of concern in light of recent evidence suggesting the increased risks of nephrotoxicity and red man syndrome when Cmin ⩾15 μg/mL and doses ⩾10 mg/kg in children. As far as we know, this is the first report on the lower dose of VCM in children with MRSA osteomyelitis.

scholarly journals Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?

2020 ◽  
Vol 202 (8) ◽  
Author(s):  
Michael J. Schurr
Keyword(s):  
Cystic Fibrosis ◽  
Staphylococcus Aureus ◽  
Pseudomonas Aeruginosa ◽  
Cell Membrane ◽  
Membrane Integrity ◽  
Partial Explanation ◽  
Content Type ◽  
First Report ◽  
Cell Membrane Integrity ◽  
Link Type

ABSTRACT In this issue of Journal of Bacteriology, Price et al. show that the Pseudomonas aeruginosa-produced exopolysaccharide alginate protects Staphylococcus aureus by dampening the expression of P. aeruginosa virulence products that usually inhibit S. aureus respiration and cell membrane integrity when the two organisms compete in other environments (C. E. Price, D. G. Brown, D. H. Limoli, V. V. Phelan, and G. A. O’Toole, J Bacteriol 202:e00559-19, 2020, https://doi.org/10.1128/jb.00559-19). This is the first report that exogenously added alginate affects P. aeruginosa competition and provides a partial explanation for S. aureus and P. aeruginosa coinfections in cystic fibrosis.

scholarly journals First report of sasX-positive methicillin-resistant Staphylococcus aureus in Japan

2017 ◽  
Vol 364 (16) ◽  
Author(s):  
Hidemasa Nakaminami ◽  
Teruyo Ito ◽  
Xiao Han ◽  
Ayumu Ito ◽  
Miki Matsuo ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Methicillin Resistant ◽  
First Report

scholarly journals First Report of Septicemia Caused by an Obligately Anaerobic Staphylococcus aureus Infection in a Human

2006 ◽  
Vol 44 (6) ◽  
pp. 2311-2313 ◽  
Author(s):  
S. L. Peake ◽  
J. V. Peter ◽  
L. Chan ◽  
R. P. Wise ◽  
A. R. Butcher ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
First Report ◽  
Obligately Anaerobic ◽  
Aureus Infection

First report of community-acquired meticillin-resistant Staphylococcus aureus from a Slovenian hospital

2011 ◽  
Vol 79 (3) ◽  
pp. 271-272 ◽  
Author(s):  
U. Dermota ◽  
I. Grmek-Košnik ◽  
M. Ravnik ◽  
A. Budimir ◽  
H. Ribič ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
First Report

scholarly journals Continuous Infusion of Nafcillin for Sternal Osteomyelitis in an Infant After Cardiac Surgery

2010 ◽  
Vol 15 (1) ◽  
pp. 49-54
Author(s):  
Chad A. Knoderer ◽  
Jennifer L. Morris ◽  
Elaine G. Cox
Keyword(s):  
Staphylococcus Aureus ◽  
Cardiac Surgery ◽  
Continuous Infusion ◽  
Surgical Debridement ◽  
First Report ◽  
Sternal Osteomyelitis

We report the use of the continuous infusion of nafcillin for the treatment of an infant who had methicillinsusceptible Staphylococcus aureus sternal osteomyelitis not responsive to traditional nafcillin dosing. The patient was successfully treated with surgical debridement and the continuous infusion of nafcillin. To our knowledge, this is the first report describing the successful use of the continuous infusion of nafcillin to treat an infant who had sternal osteomyelitis after cardiac surgery.

scholarly journals Prophylactic potential of a Panchgavya formulation against certain pathogenic bacteria

F1000Research ◽  
2018 ◽  
Vol 7 ◽  
pp. 1612 ◽  
Author(s):  
Pooja Patel ◽  
Chinmayi Joshi ◽  
Snehal Funde ◽  
Hanumanthrao Palep ◽  
Vijay Kothari
Keyword(s):  
Staphylococcus Aureus ◽  
Survival Rate ◽  
Caenorhabditis Elegans ◽  
Bacterial Infection ◽  
Pathogenic Bacteria ◽  
Bacterial Challenge ◽  
Prophylactic Efficacy ◽  
First Report ◽  
Nematode Worm

A Panchgavya preparation was evaluated for its prophylactic efficacy against bacterial infection, employing the nematode worm Caenorhabditis elegans as a model host. Worms fed with the Panchgavya preparation prior to being challenged with pathogenic bacteria had a better survival rate against four out of five test bacterial pathogens, as compared to the control worms. Panchgavya feeding prior to bacterial challenge was found to be most effective against Staphylococcus aureus, resulting in 27% (p=0.0001) better worm survival. To the best of our awareness, this is the first report demonstrating in vivo prophylactic efficacy of Panchgavya mixture against pathogenic bacteria.

Sign in / Sign up

Export Citation Format

Share Document